Articles and Insights About Wearables for Clinical Trials

Company News

VivoSense Joins the FNIH Biomarkers Consortium

 Dudley Tabakin  April 19, 2023

VivoSense announces that we have joined the Foundation for the National Institutes of Health’s (FNIH) Biomarkers Consortium! This new partnership strengthens our joint mission to facilitate the development of novel digital biomarkers using new and existing technologies, including evidence for their qualification in diagnostic medicine, therapeutic development, and clinical practice improvement.

Read More

VivoSense Joins Clinical Trials Transformation Initiative (CTTI)

 Dudley Tabakin  March 22, 2023

VivoSense, Inc. has joined the Clinical Trials Transformation Initiative (CTTI) to advance the efficiency and efficacy of clinical trial research and care. As a leading provider of digital endpoint solutions derived from wearable sensors, VivoSense will contribute to CTTI's foundational efforts to improve quality, patient engagement, novel trial design, digital health trials, investigator, and site support and ethics in research.

Read More

VivoSense Announces Expanded Collaboration with RSRT

 Dudley Tabakin  March 7, 2023

VivoSense announces an expansion of our collaboration with the Rett Syndrome Research Trust (RSRT). Building on the success of our previous collaborations, VivoSense and RSRT will continue to support the development of treatments for Rett Syndrome (RTT) by qualifying objective digital outcome measures of breathing problems for use in RTT trials.

Read More

VivoSense Marks Rare Disease Day

 Dudley Tabakin  February 28, 2023

VivoSense recognizes Rare Disease Day by minding the importance of discovering new advancements in research and clinical trials to care for those with rare diseases. There are approximately 30 million Americans living with rare diseases today, and research into new therapies is imperative for these patients.

Read More

VivoSense Joins DiMe's Core Measures of Sleep Project

 Kate Lyden  February 1, 2023

We are excited to announce our participation in the Digital Medicine Society's (DiMe) latest digital clinical measures project, Core Measures of Sleep. In partnership with the Digital Medicine Society and other leaders in the field, we are paving the way for better approaches to collecting, analyzing, and interpreting sleep data.

Read More

VivoSense Awarded NIA/MassAITC Grant to Aid in Alzheimer's Research

 Dudley Tabakin  January 19, 2023

VivoSense, a trusted leader in the development, validation, and delivery of digital clinical measures, announced today that it has been awarded a research grant funded by the National Institute of Aging (NIA) and the Massachusetts Artificial Intelligence and Technology Center for Connected Care in Aging & Alzheimer’s Disease (MassAITC; grant number 5P30AG073107-02 Pilot A2).

Read More

VivoSense Joins DiMe Physical Activity Project

 Kate Lyden  October 31, 2022

We are excited to announce our participation in DiMe's Physical Activity, the latest digital clinical measures project. In partnership with the Digital Medicine Society (DiMe) and other leaders in the field, we are developing a core set of digital measures for tracking patients’ physical activity across any therapeutic area.

Clinicians, researchers, and drug developers need to have a shared baseline of digital measures to improve our patients’ health, regardless of their disease or condition. By taking an omni-therapeutic approach, we believe we can reduce time and risk, speeding the development of new therapies to market. Read more about the project.

Read More

Digital Health Expert, Ieuan Clay, Joins VivoSense Science Team

 Rob Wilson  June 16, 2022

Vivosense is pleased to announce that Ieuan Clay has joined the company as Director of Science. He brings extensive knowledge in developing and validating novel digital measures gained across experiences in industry, healthtech and academia.

Read More

VivoSense Joins DTRA to Accelerate Adoption of Decentralized Trials

 Rob Wilson  June 9, 2022

VivoSense, an agile end-to-end digital clinical endpoint solutions company developing digital endpoints from wearable sensors with their proprietary AI-enabled software platform is proud to join an alliance of over one hundred and twenty life sciences and healthcare organizations that seek to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The Decentralized Trials & Research Alliance (DTRA), is uniting industry stakeholders, including healthcare companies, regulators, patient groups, research organizations and technology providers with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.

Read More

Stijn Rogiers Interview About Accelerating Digital Endpoints

 Stijn Rogiers  May 26, 2022

SAS Principal Industry Consultant Stijn Rogiers interviewed VivoSense CEO Dudley Tabakin about the uptake in decentralized clinical trials in response to the ongoing disruptions caused by the Coronavirus pandemic of 2020. As trials move toward decentralization, new processes and strategies are required to effectively collect and analyze patient data in a meaningful and validated way. Here are a few key takeaways from their conversation.

Read More

Subscribe to Email Updates

Stay Connected

Popular